Breaking News

Alphatec Spine Replaces Resigning Board Member

By Alphatec Holdings Inc. | February 14, 2017

New member brings more than 28 years of orthopedic and medical device experience to the firm.

Alphatec Holdings Inc., parent company of Alphatec Spine Inc., a provider of spinal fusion technologies, has appointed David H. Mowry as a member of the board of directors effective Feb. 8. Mowry is  replacing Siri S. Marshall, who resigned the same day. Mowry is qualified as an independent director under the definition established by Nasdaq.
 
Mowry is president and CEO of Vyaire Medical, a global developer of respiratory diagnostics, ventilation, and anesthesia delivery and patient monitoring technologies. Prior to Vyaire Medical, Mowry held senior leadership positions within the orthopedics, spine and medical device industries, including chief operating officer at Wright Medical Group N.V. until 2016 and president and CEO of Tornier N.V. from 2013 to 2015. Within the spine industry, Mowry served as vice president of operations and logistics at Zimmer Spine. Mowry intends on limiting his board participation to Alphatec (outside of Vyaire) in order to fully engage with Alphatec and remain focused on helping the company pursue its goals.
 
“Dave brings a wealth of proven business and leadership experience within the orthopedic and spine industries,” said Terry Rich, CEO of Alphatec Spine. “Dave has been a key mentor in my career and I am excited to work with him again. His decision to join the board demonstrates confidence in our vision and ability to build a high-growth U.S. spine company through innovation and value creation.  We look forward to his counsel and benefitting from his impressive background and expertise.”

Mowry, 54, has served as president and CEO of Vyaire Medical since May 2016. From October 2015 to May 2016 he served as executive vice president and chief operating officer and member of the board of directors of Wright Medical Group N.V. Between September 2015 and November 2016 he was a member of the board of directors of EndoChoice Holdings Inc. Prior to Wright Medical, Mowry served as president and CEO and member of the board of directors of Tornier N.V. from February 2013 until completing the merger with Wright Medical in October 2015 and as chief operating officer of Tornier from 2011 to 2013. Prior to this, Mowry held executive leadership positions at Covidien, ev3, and Zimmer Spine. Mowry received a bachelor of science degree in engineering from the United States Military Academy at West Point.
 
“Alphatec is at a pivotal point in its evolution with a strong portfolio of spinal fusion products, its focus on the U.S. market and its new, spine-experienced leadership team," Mowry said. "I have had the pleasure of working with Terry and several of his new commercial leaders in the past. We share a common approach for delivering results and I am excited about being engaged with him and his team.  I look forward to contributing to the achievement of their strategic goals and supporting Alphatec’s future growth.”
 
Alphatec Spine, a wholly owned subsidiary of Alphatec Holdings Inc., designs, develops, and markets spinal fusion technology products and solutions for the treatment of spinal disorders associated with disease and degeneration, congenital deformities and trauma. The company's mission is to improve lives by delivering advancements in spinal fusion technologies. The company is based in Carlsbad, Calif.

Related News:

Related Markets:

  • Loading Orthopedic Devices with Biologics and Pharmaceuticals

    Loading Orthopedic Devices with Biologics and Pharmaceuticals

    Dr. Kevin Nelson, Founder and CSO, TissueGen Inc.||May 19, 2017
    Fiber technology enables the delivery of the therapeutic components via a biodegradable platform that can be implanted.

  • Looking Beneath the Surface

    Looking Beneath the Surface

    Sam Brusco, Associate Editor||May 19, 2017
    Surface treatments seek to improve orthopedic device usability, longevity, and bone integration.

  • Going to Extremes

    Going to Extremes

    Michael Barbella, Managing Editor||May 19, 2017
    The innovation and market value found in extremity solutions is prompting a change of heart among major orthopedic firms.